GILEAD SCIENCES ANNOUNCES THIRD QUARTER 2026 FINANCIAL RESULTS
Revenue$8.2 billion+16% YoY
EPS$1.94
Outlookraisedguidance
Company · GILD
Gilead Sciences, Inc.
Earnings coverage
0Articles
2Earnings releases
0Topics
GILD
Gilead Sciences, Inc. · NASDAQ NMS - GLOBAL MARKET
$170.68
▲ +5.07 (+3.06%)
Open$170.25
Prev close$165.61
Day low$169.00
Day high$175.65
52-week high$165.70
52-week low$114.02
Market cap$211.6B
Avg volume6.3M
P/E (TTM)24.87
EPS (TTM)$-3.15
Div. yield3.98%
Beta0.39
Revenue growth+6.54%
Net margin-12.5%
ROE-21.8%
Shares out.1.24B
Delayed up to 15 min · Source: Finnhub · Not investment advice
GILEAD SCIENCES ANNOUNCES SECOND QUARTER 2026 FINANCIAL RESULTS
Revenue$7.6 billion+10% YoY
EPS$1.56
Outlookraisedguidance
Market data
Widgets by TradingView. They load only when you click, so the page stays fast.